Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sagar A. Vaidya is active.

Publication


Featured researches published by Sagar A. Vaidya.


Immunity | 2002

IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program

Sean E. Doyle; Sagar A. Vaidya; Ryan M. O'Connell; Hajir Dadgostar; Paul W. Dempsey; Ting-Ting Wu; Govinda Rao; Ren Sun; Margaret E. Haberland; Robert L. Modlin; Genhong Cheng

We have identified a subset of genes that is specifically induced by stimulation of TLR3 or TLR4 but not by TLR2 or TLR9. Further gene expression analyses established that upregulation of several primary response genes was dependent on NF-kappaB, commonly activated by several TLRs, and interferon regulatory factor 3 (IRF3), which was found to confer TLR3/TLR4 specificity. Also identified was a group of secondary response genes which are part of an autocrine/paracrine loop activated by the primary response gene product, interferon beta (IFNbeta). Selective activation of the TLR3/TLR4-IRF3 pathway potently inhibited viral replication. These results suggest that TLR3 and TLR4 have evolutionarily diverged from other TLRs to activate IRF3, which mediates a specific gene program responsible for innate antiviral responses.


Journal of Experimental Medicine | 2004

Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection

Ryan M. O'Connell; Supriya K. Saha; Sagar A. Vaidya; Kevin W. Bruhn; Gustavo A. Miranda; Brian Zarnegar; Andrea K. Perry; Bidong O. Nguyen; Timothy F. Lane; Tadatsugu Taniguchi; Jeff F. Miller; Genhong Cheng

Numerous bacterial products such as lipopolysaccharide potently induce type I interferons (IFNs); however, the contribution of this innate response to host defense against bacterial infection remains unclear. Although mice deficient in either IFN regulatory factor (IRF)3 or the type I IFN receptor (IFNAR)1 are highly susceptible to viral infection, we show that these mice exhibit a profound resistance to infection caused by the Gram-positive intracellular bacterium Listeria monocytogenes compared with wild-type controls. Furthermore, this enhanced bacterial clearance is accompanied by a block in L. monocytogenes–induced splenic apoptosis in IRF3- and IFNAR1-deficient mice. Thus, our results highlight the disparate roles of type I IFNs during bacterial versus viral infections and stress the importance of proper IFN modulation in host defense.


Molecular Cell | 2003

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

Antonio Castrillo; Sean B. Joseph; Sagar A. Vaidya; Margaret E. Haberland; Alan M. Fogelman; Genhong Cheng; Peter Tontonoz

The liver X receptors (LXR) alpha and beta are regulators of cholesterol metabolism and determinants of atherosclerosis susceptibility. Viral and bacterial pathogens have long been suspected to be modulators of atherogenesis; however, mechanisms linking innate immunity to cholesterol metabolism are poorly defined. We demonstrate here that pathogens interfere with macrophage cholesterol metabolism through inhibition of the LXR signaling pathway. Activation of Toll-like receptors (TLR) 3 and 4 by microbial ligands blocks the induction of LXR target genes including ABCA1 in cultured macrophages as well as in aortic tissue in vivo. As a consequence of these transcriptional effects, TLR3/4 ligands strongly inhibit cholesterol efflux from macrophages. Crosstalk between LXR and TLR signaling is mediated by IRF3, a specific effector of TLR3/4 that inhibits the transcriptional activity of LXR on its target promoters. These findings highlight a common mechanism whereby bacterial and viral pathogens may modulate macrophage cholesterol metabolism and cardiovascular disease.


Journal of Experimental Medicine | 2004

Toll-like Receptors Induce a Phagocytic Gene Program through p38

Sean E. Doyle; Ryan M. O'Connell; Gustavo A. Miranda; Sagar A. Vaidya; Edward K. Chow; Philip T. Liu; Shinobu Suzuki; Nobutaka Suzuki; Robert L. Modlin; Wen Chen Yeh; Timothy F. Lane; Genhong Cheng

Toll-like receptor (TLR) signaling and phagocytosis are hallmarks of macrophage-mediated innate immune responses to bacterial infection. However, the relationship between these two processes is not well established. Our data indicate that TLR ligands specifically promote bacterial phagocytosis, in both murine and human cells, through induction of a phagocytic gene program. Importantly, TLR-induced phagocytosis of bacteria was found to be reliant on myeloid differentiation factor 88–dependent signaling through interleukin-1 receptor–associated kinase-4 and p38 leading to the up-regulation of scavenger receptors. Interestingly, individual TLRs promote phagocytosis to varying degrees with TLR9 being the strongest and TLR3 being the weakest inducer of this process. We also demonstrate that TLR ligands not only amplify the percentage of phagocytes uptaking Escherichia coli, but also increase the number of bacteria phagocytosed by individual macrophages. Taken together, our data describe an evolutionarily conserved mechanism by which TLRs can specifically promote phagocytic clearance of bacteria during infection.


Journal of Immunology | 2003

Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 4

Sean E. Doyle; Ryan M. O'Connell; Sagar A. Vaidya; Edward K. Chow; Kathleen M. Yee; Genhong Cheng

We have recently described an IFN regulatory factor 3-mediated antiviral gene program that is induced by both Toll-like receptor (TLR)3 and TLR4 ligands. In our current study, we show that activation of IFN/viral response gene expression in primary macrophage cells is stronger and prolonged with TLR3 stimulation compared with that of TLR4. Our data also reveal that the cytoplasmic tails of both TLR3 and TLR4 can directly interact with myeloid differentiation factor 88 (MyD88). However, although Toll/IL-1 receptor homology domain-containing adaptor protein/MyD88 adaptor-like is able to associate with TLR4, we were unable to detect any interaction between Toll/IL-1 receptor homology domain-containing adaptor protein/MyD88 adaptor-like and TLR3. By using quantitative real-time PCR assays, we found that TLR3 expression is inducible by both TLR3 and TLR4 ligands, while TLR4 expression is not inducible by these same stimuli. Furthermore, using cells derived from mice deficient in the IFN-αβR, we show that both TLR3 and TLR4 require IFN-β autocrine/paracrine feedback to induce TLR3 expression and activate/enhance genes required for antiviral activity. More specifically, a subset of antiviral genes is initially induced independent of IFN-β, yet the cytokine further enhances expression at later time points. This was in contrast to a second set of genes (including TLR3) that is induced only after IFN-β production. Taken together, our data argue that, despite both TLR3 and TLR4 being able to use IFN-β to activate/enhance antiviral gene expression, TLR3 uses multiple mechanisms to enhance and sustain the antiviral response more strongly than TLR4.


Cellular and Molecular Life Sciences | 2003

The art of war: Innate and adaptive immune responses.

Paul W. Dempsey; Sagar A. Vaidya; Genhong Cheng

Research over the last several years has greatly advanced our understanding of the mechanisms by which the immune system functions. There exist two main branches of immunity, termed innate and adaptive immunity. Innate immunity uses the genetic memory of germline-encoded receptors to recognize the molecular patterns of common pathogens. Adaptive immunity, akin to somatic memory, is a complex system by which the body learns to recognize a pathogen’s unique antigens and builds an antigen specific response to destroy it. The effective development of the overall immune response depends on careful interplay and regulation between innate and adaptive immunity. Here we review our current understanding of how these integrated systems distinguish targets against which a response is appropriate and neutralize potentially pathogenic challenges.


Journal of Immunology | 2005

Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 1

Ryan M. O’Connell; Sagar A. Vaidya; Andrea K. Perry; Supriya K. Saha; Paul W. Dempsey; Genhong Cheng

Type I IFNs are well established antiviral cytokines that have also been shown to be induced by bacteria. However, the signaling mechanisms regulating the activation of these cytokines during bacterial infections remain poorly defined. We show that although Gram-negative bacteria can activate the type I IFN pathway through TLR4, the intracellular Gram-positive bacterium Listeria monocytogenes (LM) can do so independently of TLR4 and TLR2. Furthermore, experiments using genetic mutants and chemical inhibitors suggest that LM-induced type I IFN activation occurs by an intracellular pathway involving the serine-threonine kinase TNFR-associated NF-κB kinase (TANK)-binding kinase 1 (TBK1). Interestingly, receptor-interacting protein 2, a component of the recently discovered nucleotide-binding oligomerization domain-dependent intracellular detection pathway, was not involved. Taken together, our data describe a novel signal transduction pathway involving TBK1 that is used by LM to activate type I IFNs. Additionally, we provide evidence that both the LM- and TLR-dependent pathways converge at TBK1 to activate type I IFNs, highlighting the central role of this molecule in modulating type I IFNs in host defense and disease.


Current Opinion in Immunology | 2003

Toll-like receptors and innate antiviral responses

Sagar A. Vaidya; Genhong Cheng

Toll-like receptors (TLRs) have a unique and important role in detecting the presence of pathogenic infection. TLRs can recognize conserved structures from a wide variety of microorganisms, such as bacteria, mycobacteria, spirochetes and yeast. However, they are generally not thought to play a major role in viral infection. Several reports have now identified distinct viral ligands for the TLRs, and evidence is accumulating for a functional role of the TLRs in mediating antiviral effector mechanisms.


Journal of Clinical Microbiology | 2006

Pelvic Abscess Due to Ochrobactrum anthropi in an Immunocompetent Host: Case Report and Review of the Literature

Sagar A. Vaidya; Diane M. Citron; Marjorie B. Fine; Georgette Murakami; Ellie J. C. Goldstein

Ochrobactrum anthropi infection is rare in humans and is generally associated with immunocompromised hosts with indwelling foreign bodies. We report a case of pelvic abscess with O. anthropi after a routine appendectomy in an immunocompetent patient and review the literature on O. anthropi infection in patients with normal immune function.


Journal of Clinical Microbiology | 2006

Pelvic abscess due to Ochrobactrum intermedium [corrected] in an immunocompetent host: case report and review of the literature.

Sagar A. Vaidya; Diane M. Citron; Marjorie B. Fine; Georgette Murakami; Ellie J. C. Goldstein

ABSTRACT Ochrobactrum anthropi infection is rare in humans and is generally associated with immunocompromised hosts with indwelling foreign bodies. We report a case of pelvic abscess with O. anthropi after a routine appendectomy in an immunocompetent patient and review the literature on O. anthropi infection in patients with normal immune function.

Collaboration


Dive into the Sagar A. Vaidya's collaboration.

Top Co-Authors

Avatar

Genhong Cheng

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Diane M. Citron

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sean E. Doyle

University of California

View shared research outputs
Top Co-Authors

Avatar

Edward K. Chow

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge